Search
Researchers are developing uses for a drug that could benefit many people with lung cancer.
Go behind the scenes with Filemon Dela Cruz, who cares for children with sarcoma and conducts precision medicine research at Memorial Sloan Kettering.
Researchers have found the first evidence that susceptibility to developing acute lymphoblastic leukemia during childhood may be heritable.
A new MSK study finds that in colorectal cancer, not all regulatory T cells are created equal. One subtype suppresses cancer growth while another aids it. The findings could help improve immunotherapy treatment for the majority of patients with colorectal cancer, and potentially for other cancers.
Advances in diagnosis and treatment, especially those made over the past ten years, have played a significant role in the decline in cancer deaths. Learn about those advances — and what to expect in the next ten years.
Read about MSK research that sheds light on how the innate immune system interacts with developing cancer cells.
Isabel Lam, a 2016 alumnae of Gerstner Sloan Kettering, has been awarded the Chairman’s Prize for her first-author paper “Nonparadoxical evolutionary stability of the recombination initiation landscape in yeast,” published in Science in 2015.
Developmental biologist Dr. Alexandra Joyner reflects on her career and talks about the new passions she looks forward to pursuing in retirement.
The updated dietary guidelines from the federal government have caused confusion, but MSK dietitians' recommendations have not changed: A diet that is mostly plant based is still considered the most healthy.
New MSK research finds the TCA cycle’s waste-management function may present an opportunity against cancer; shows how microplastics impair immune ‘housekeeping’ functions; reveals the way the protein TOX plays different roles in different immune cells; and identifies a new combination approach for treating advanced kidney cancer after immunotherapy.